These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11206236

  • 21. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
    Tohda Y, Miyamoto T.
    Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
    [Abstract] [Full Text] [Related]

  • 22. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B.
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [Abstract] [Full Text] [Related]

  • 23. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG, Mendelson LM, Pearlman DS.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.
    Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H.
    BMC Pulm Med; 2010 Jan 05; 10():1. PubMed ID: 20051135
    [Abstract] [Full Text] [Related]

  • 26. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M, Jarvis B.
    Drugs; 2001 Jan 05; 61(9):1325-50. PubMed ID: 11511026
    [Abstract] [Full Text] [Related]

  • 27. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH, Krouse HJ, Janisse JJ.
    Clin Drug Investig; 2009 Jan 05; 29(1):51-8. PubMed ID: 19067474
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH, Howland WC, Lumry WR.
    Ann Allergy Asthma Immunol; 2001 Jun 05; 86(6):627-32. PubMed ID: 11428734
    [Abstract] [Full Text] [Related]

  • 32. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
    Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM.
    Chest; 2000 Dec 05; 118(6):1538-46. PubMed ID: 11115437
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.
    Meltzer EO, Wenzel S.
    J Asthma; 2006 Dec 05; 43(10):765-72. PubMed ID: 17169829
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate.
    Chervinsky P, Nelson HS, Bernstein DI, Berkowitz RA, Siegel SC.
    Int J Clin Pract; 2002 Dec 05; 56(6):419-25. PubMed ID: 12166539
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.